Anti-angiogenic activity of julibroside J8, a natural product isolated from Albizia julibrissin

Phytomedicine

Volumn 16, Issue 8, 2009, Pages 703-711

  Hua, Hui ^a   Feng, Lei ^a   Zhang, Xiao ping ^a   Zhang, Lian fen ^b   Jin, Jian ^b  

^a JIANGNAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Angiogenesis; Ginsenoside Rg3; Human microvascular endothelial cell; Julibroside J8

Indexed keywords

ANGIOGENESIS INHIBITOR; CYTOTOXIC AGENT; GINSENOSIDE RG 3; JULIBROSIDE J8; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG;

ALBIZIA JULIBRISSIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; ASSAY; CANCER GROWTH; CELL GROWTH; CELL MIGRATION; CHORIOALLANTOIS; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; MEDICINAL PLANT; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL;

ALBIZZIA; ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE; CELL LINE, TUMOR; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HUMANS; MICE; MICROVESSELS; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; PLANT STEMS; PLANTS, MEDICINAL; POLYSACCHARIDES; SAPONINS;

ALBIZIA JULIBRISSIN; MUS MUSCULUS;

EID: 67349203822     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.01.002     Document Type: Article

References (15)

1. Bussolino F., Mantovani A., and Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem. Sci. 22 (1997) 251-625
2. Cao Y., O'Reilly M.S., Marshall B., Flynn E., and Ji R.W. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produce long-term dormancy of metastases. J. Clin. Invest. 101 (1998) 1055-1163
3. Fox S.B., Leek R.D., Weekes M.P., Whitehouse R.M., Gatter K.C., and Harris A.L. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, chalkley count, and computer image analysis. J. Pathol. 177 (1995) 275-283
4. Folkman J., and Shing Y. Angiogenesis. J. Biol. Chem. 267 (1992) 10931-10934
5. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
6. Kamphaus G.D., Colorado P.C., Panka D.J., Hopfer H., and Ramchandran R. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J. Biol. Chem. 275 (2000) 1209-1215
7. Kubota Y., Kleinman H.K., Martin G.R., and Lawley T.J. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J. Cell Biol. 107 (1988) 1589-1598
8. O'Reilly M.S. The preclinical evaluation of angiogenesis inhibitors. Invest. New Drugs 15 (1997) 5-13
9. Soeda S., Kozako T., Iwata K., and Shimeno H. Oversulfated fucoidan inhibits the basic fibroblast growth factor-induced tube formation by human umbilical vein endothelial cells: its possible mechanism of action. Biochim. Biophys. Acta 1497 (2000) 127-134
10. Song Y.S., Kim S.H., Sa J.H., Jin C., Lim C.J., and Park E.H. Anti-angiogenic, antioxidant and xanthine oxidase inhibition activities of the mushroom Phellinus linteus. J. Ethnopharmacol. 88 (2003) 113-116
11. Valster A., Tran N.L., Nakada M., Berens M.E., Chan A.Y., and Symons M. Cell migration and invasion assays. Methods 37 (2005) 208-215
12. Van Hinsbergh V.W., Collen A., and Koolwijk P. Angiogenesis and anti-angiogenesis: perspectives for the treatment of solid tumors. Ann. Oncol. 10 (1999) 560-563
13. 8-induced HeLa cell apoptosis through caspase pathway. J. Asian Nat. Prod. Res. 8 (2006) 457-465
14. Zhu Y.P. Chinese Materia Medica Chemistry, Pharmacology and Applications (1998), Harwood Academic Publishers, Netherlands (pp. 519-520)
15. Zou K., Tong W.Y., Liang H., Cui J.R., Tu G.Z., Zhao Y.Y., and Zhang R.Y. Diastereoisomeric saponins from Albizia julibrissin. Carbohydr. Res. 340 (2005) 1329-1334